Latest Breaking News On - Jubilant pharma ltd - Page 3 : comparemela.com
Plus Therapeutics Announces the Appointment of Industry Veteran, Norman LaFrance, M D , as the Company s Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma to remain integral to group after reorganisation: S&P
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma to remain integral to group after reorganisation: S&P
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma to Remain Integral to Group After Reorganisation: S&P
moneylife.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneylife.in Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma ratings unaffected by proposed reorganisation: Fitch ANI | Updated: Jul 30, 2021 12:20 IST
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd s (JPL s) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL s ratings, says Fitch Ratings.
The reorganisation is unlikely to change assessment of linkages between JPL and JPHL. Thus Fitch will continue to rate JPL based on the parent s consolidated profile which will remain unaffected by the reorganisation.
Fitch expects JPL s financial profile to remain comfortable as the API business s limited earnings contribution will minimise the impact.
JPHL aims to complete the reorganisation over the next year, subject to receipt of certain regulatory and other approvals, including from the lenders.